Evidence map›Paper›PMID 30554562›Full record

ArticlePsychiatric services (Washington, D.C.)2019

Benzodiazepine Use and Misuse Among Adults in the United States.

Donovan T Maust, Lewei A Lin, Frederic C Blow

Open access · bronzeAbstract read
In one paragraph

Article in Psychiatric services (Washington, D.C.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed, 9 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 9 syntheses or guidelines pooled it, 311 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. A Systematic Review of the Risks of Motor Vehicle Crashes Associated with Psychiatric Disorders.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Donovan T MaustDepartment of Psychiatry, University of Michigan, Ann Arbor, and Center for Clinical Management Research, Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor.
Lewei A LinDepartment of Psychiatry, University of Michigan, Ann Arbor, and Center for Clinical Management Research, Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor.
Frederic C BlowDepartment of Psychiatry, University of Michigan, Ann Arbor, and Center for Clinical Management Research, Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor.
VA Ann Arbor Healthcare System · US

Funding

Leveraging large-scale national data to understand, reduce, and prevent benzodiazepine-related harms among older adultsR01DA045705 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MAUST, DONOVAN T · 2018 to 2022
$2.5M
NIDA NIH HHS R01 DA045705
6 · The paper itself

Abstract

objectiveGoals were to determine the prevalence of benzodiazepine use (as prescribed and misuse), characterize misuse, and examine variation by age.

methodsA cross-sectional analysis was conducted of 2015 and 2016 National Survey on Drug Use and Health data limited to adults ≥18 (N=86,186) and data from those respondents reporting benzodiazepine use (N=10,290). Measurements included past-year prescription benzodiazepine use and misuse ("any way a doctor did not direct"), substance use disorders, mental illness, and demographic characteristics. Misuse was compared between younger (18-49) and older (≥50) adults.

resultsA total of 30.6 million adults (12.6%) reported past-year benzodiazepine use-25.3 million (10.4%) as prescribed and 5.3 million (2.2%) misuse. Misuse accounted for 17.2% of overall use. Adults ages 50-64 had the highest prescribed use (12.9%). Those ages 18-25 had the highest misuse (5.2%), and those ages ≥65 had the lowest (.6%). Misuse and abuse of or dependence on prescription opioids or stimulants were strongly associated with benzodiazepine misuse. Benzodiazepine misuse without a prescription was the most common type of misuse, and a friend or relative was the most common source. Adults ages ≥50 were more likely than younger adults to use a benzodiazepine more often than prescribed and to use a benzodiazepine to help with sleep.

conclusionsBenzodiazepine use among U.S. adults was higher than previously reported, and misuse accounted for nearly 20% of use overall. Use by adults ages 50-64 now exceeds use by those ages ≥65. Patients also prescribed stimulants or opioids should be monitored for benzodiazepine misuse. Improved access to behavioral interventions for sleep or anxiety may reduce some misuse.

Indexed as

AdolescentAdultAgedAge FactorsBenzodiazepinesCross-Sectional StudiesDrug PrescriptionsFemaleHumansMaleMiddle AgedPrescription Drug MisusePrevalenceUnited StatesYoung AdultBenzodiazepinesAlcohol and drug abuseBenzodiazepinesGeriatric psychiatry

Identifiers

PMID30554562
PMCPMC6358464
OpenAlexW2904755589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.